Geron (GERN) Accumulated Expenses (2010 - 2026)
Geron's (GERN) quarterly Accumulated Expenses came in at $31.0 million in Q1 2026, up 7.2% year-on-year from $28.9 million in Q1 2025, and up 1.53% quarter-over-quarter from $30.5 million in Q4 2025.
Geron (GERN) Accumulated Expenses (2010 - 2026) Analysis & Trends
Geron has disclosed Accumulated Expenses across 17 years of filings, most recently posting $31.0 million for Q1 2026.
- Accumulated Expenses for Q1 2026 came in at $31.0 million, up 7.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.0 million (up 7.2% YoY), and the FY2025 annual result was $30.5 million, down 14.21% from the prior year.
- Accumulated Expenses came in at $31.0 million for Q1 2026 at Geron, up from $30.5 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $53.1 million in Q3 2022 to a low of $393000.0 in Q1 2022.
- The 5-year median for Accumulated Expenses is $13.8 million (2023), against an average of $18.6 million.
- Across the five-year window, Accumulated Expenses plunged 98.01% in 2022 and surged 6519.86% in 2024, its largest moves.
- Geron's Accumulated Expenses stood at $33.1 million in 2022, then plunged by 58.43% to $13.8 million in 2023, then soared by 158.37% to $35.5 million in 2024, then decreased by 14.21% to $30.5 million in 2025, then rose by 1.53% to $31.0 million in 2026.
- The last three Accumulated Expenses figures came in at $31.0 million (Q1 2026), $30.5 million (Q4 2025), and $16.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Geron | 729,618.77 | 729,618.77 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.97 Mn |
| Dec 31, 2025 | 30.50 Mn |
| Sep 30, 2025 | 16.39 Mn |
| Jun 30, 2025 | 11.34 Mn |
| Mar 31, 2025 | 28.89 Mn |
| Dec 31, 2024 | 35.55 Mn |
| Sep 30, 2024 | 853,000.00 |
| Jun 30, 2024 | 38.66 Mn |
| Mar 31, 2024 | 896,000.00 |
| Dec 31, 2023 | 13.76 Mn |
| Sep 30, 2023 | 7.94 Mn |
| Jun 30, 2023 | 584,000.00 |
| Mar 31, 2023 | 4.91 Mn |
| Dec 31, 2022 | 33.10 Mn |
| Sep 30, 2022 | 53.11 Mn |
| Jun 30, 2022 | 8.76 Mn |
| Mar 31, 2022 | 393,000.00 |
| Dec 31, 2021 | 8.10 Mn |
| Sep 30, 2021 | 6.89 Mn |
| Jun 30, 2021 | 7.66 Mn |